The diagnosis of MM is primarily based on an elevated clonal plasma cell count (or plasmacytoma) and nowadays less importantly of the M protein and disease defining CRAB criteria (hypercalcemia, renal insufficiency, anemia, and osteolytic bone destruction). Here, MYOM2 is linked to Miyoshi myopathy.